Most recently, it has been discovered that conolidine and the above derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in equivalent spots as classical opioid receptors, it binds into a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor